Global Clinical Trial Management Systems (CTMS) Market 2022


Description

According to a report by StrategyHelix, the global CTMS market is set to increase by US$ 981.8 million during 2022-2028, growing at a CAGR of 11.6% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for CTMS. The global CTMS market is segmented on the basis of product, deployment mode, delivery mode, and region. On the basis of product, the global CTMS market has been segmented into services, software. The software segment is estimated to account for the largest share of the global CTMS market. By deployment mode, the global CTMS market has been segmented into enterprise-based CTMS, site-based CTMS. The enterprise-based CTMS segment held the largest revenue share in 2021. Based on delivery mode, the global CTMS market is categorized into cloud-based, on-premise, web-based. Globally, the web-based segment made up the largest share of the CTMS market. Geographically, the global CTMS market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global CTMS market in 2021.

The global CTMS market is highly competitive. The CTMS market is dominated by key players, which are Advarra Inc., ArisGlobal LLC, Clario (Bioclinica), DataTrak International Inc., IBM Corporation, Medidata Solutions Inc., Oracle Corporation, Paraxel International Corporation, Veeva Systems Inc. Competitive landscape gives a description of the competitive nature of the global CTMS market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the CTMS market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: services, software
Deployment mode: enterprise-based CTMS, site-based CTMS
Delivery mode: cloud-based, on-premise, web-based
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Advarra Inc., ArisGlobal LLC, Clario (Bioclinica), DataTrak International Inc., IBM Corporation, Medidata Solutions Inc., Oracle Corporation, Paraxel International Corporation, Veeva Systems Inc.


Key Benefits for Stakeholders

– Get a comprehensive picture of the global CTMS market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. CTMS market overview
Part 3. Market breakdown by product
– Services
– Software
Part 4. Market breakdown by deployment mode
– Enterprise-based CTMS
– Site-based CTMS
Part 5. Market breakdown by delivery mode
– Cloud-based
– On-premise
– Web-based
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Advarra, Inc.
– ArisGlobal LLC
– Clario (Bioclinica)
– DataTrak International, Inc.
– IBM Corporation
– Medidata Solutions Inc.
– Oracle Corporation
– Paraxel International Corporation
– Veeva Systems Inc.
About StrategyHelix
Disclaimer


USD 350

Want to customize this report? Our industry specialist will collaborate with you to deliver tailored data within a limited timeframe.
Scroll to Top

Request Free Sample Report

Global Clinical Trial Management Systems (CTMS) Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Clinical Trial Management Systems (CTMS) Market 2022

Please fill out our form and we will get back to you.

login